03/01/2018 01:00 PM EST
Recently, HHS approved new measures for tracking ADEs, including 2020 target goals for reducing them. To expand on current efforts that aim to achieve these targets by 2020, ODPHP, AHRQ, CDC, FDA, VHA, and CMS hosted a webinar on September 28, 2017. Speakers included leaders from the 3 federal interagency workgroups representing each of the targeted drug classes (opioids, anticoagulants, and diabetes agents).